The Severity of COVID-19 in Diabetes Patients

被引：1
|
作者：
Danao, Kishor [1 ]
Rokde, Vijayshri [1 ]
Bali, Nikhil [2 ]
Mahajan, Ujwala [1 ]
机构：
[1] Dadasaheb Balpande Coll Pharm, Dept Pharmaceut Chem, Nagpur 440037, Maharashtra, India
[2] Rashtrasant Tukadoji Maharaj Nagpur Univ RTMNU, Dept Pharmaceut, Nagpur 440033, Maharashtra, India
来源：
CURRENT DIABETES REVIEWS | 2023年 / 19卷 / 05期
关键词：
Diabetes; COVID-19; ARBs; drug therapy; SARS-CoV-2; innate immunity; GLUCOSE-LEVELS; MORTALITY; MELLITUS; CORONAVIRUS; INFECTION; LOCKDOWN; INDIA; CARE;
D O I：
10.2174/1573399819666221006103113
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Aims Diabetic patients are significantly stimulated by COVID-19 infection. The dreadful risk of COVID-19 mortality may be affected. In order to preserve precious lives, it is essential to comprehend how diabetes and COVID-19 are related, as well as how to manage diabetes. We aimed to focus on the mechanism, impact, and drug treatment of diabetes in COVID-19 patients. Methods A comprehensive scrutiny of the published literature in diverse pharmaceutical and medical databases such as Google Scholar, PubMed, Science Direct, DOAJ etc., were successfully conducted and classified accordingly. Results We discussed the severity of COVID-19 in diabetes patients. A patient with diabetes has a higher risk of COVID-19 mortality by influencing the development and prognosis of the disease. The recommended drugs for diabetes treatment in COVID-19 may reduce COVID-19 mortality. Conclusion Metabolic syndrome diabetes is a risk factor enhancing the development and diagnosis of COVID-19. In order to treat diabetic patients who have COVID-19 infection, insulin is preferable over oral hypoglycemic medications.
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Retinol Levels and Severity of Patients with COVID-19
    Carvalho, Maria Clara da Cruz
    Araujo, Julia Kaline Carvalho Pereira
    da Silva, Ana Gabriella Costa Lemos
    da Silva, Nayara Sousa
    de Araujo, Nathalia Kelly
    Luchessi, Andre Ducati
    Ribeiro, Karla Danielly da Silva
    Silbiger, Vivian Nogueira
    NUTRIENTS, 2023, 15 (21)
  • [42] Predictors of severity and mortality in COVID-19 patients
    Assal, Hebatallah Hany
    Abdel-hamid, Hoda M.
    Magdy, Sally
    Salah, Maged
    Ali, Asmaa
    Elkaffas, Rasha Helmy
    Sabry, Irene Mohamed
    EGYPTIAN JOURNAL OF BRONCHOLOGY, 2022, 16 (01)
  • [43] Diabetes and COVID-19 in Congolese patients
    Poaty, Henriette
    Poaty, Guy Emergence
    NDziessi, Gilbert
    Ngakeni, Emile Godefroy
    Makouka, Tatiana Doukaga
    Gadoua, Rene Soussa
    Ondze, Regis
    Kitembo, Lambert
    Msengui, Presley Jeanel
    Peya, Jethro Massala
    Sapoulou, Michel Gbala
    Ibata, Pascal
    Monabeka, Henri Germain
    Dokekias, Alexis Elira
    AFRICAN HEALTH SCIENCES, 2021, 21 (03) : 1100 - 1106
  • [44] COVID-19 in cancer patients
    Seneviratne, Suranjith L.
    Wijerathne, Widuranga
    Yasawardene, Pamodh
    Somawardana, Buddhika
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2022, 116 (09) : 767 - 797
  • [45] Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis
    de Almeida-Pititto, Bianca
    Dualib, Patricia M.
    Zajdenverg, Lenita
    Dantas, Joana Rodrigues
    de Souza, Filipe Dias
    Rodacki, Melanie
    Bertoluci, Marcello Casaccia
    DIABETOLOGY & METABOLIC SYNDROME, 2020, 12 (01)
  • [46] Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis
    Kumar, Ashish
    Arora, Anil
    Sharma, Praveen
    Anikhindi, Shrihari Anil
    Bansal, Naresh
    Singla, Vikas
    Khare, Shivam
    Srivastava, Abhishyant
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) : 535 - 545
  • [47] Diabetes and COVID-19; a Review of Possible Mechanisms
    Moradi-marjaneh, Reyhaneh
    Asgharzadeh, Fereshteh
    Khordad, Elnaz
    Marjaneh, Mahdi Moradi
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (21) : 2522 - 2527
  • [48] Diabetes and COVID-19: The past, the present, and the future
    Pranata, Raymond
    Henrina, Joshua
    Raffaello, Wilson Matthew
    Lawrensia, Sherly
    Huang, Ian
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 121
  • [49] COVID-19 induced Diabetes: A novel presentation
    Joshi, Samruddhi Chandrashekhar
    Pozzilli, Paolo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 191
  • [50] Diabetes and COVID-19: The potential role of mTOR
    Pinchera, B.
    Scotto, R.
    Buonomo, A. R.
    Zappulo, E.
    Stagnaro, F.
    Gallicchio, A.
    Viceconte, G.
    Sardanelli, A.
    Mercinelli, S.
    Villari, R.
    Foggia, M.
    Gentile, I
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
12345